The Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD Deficiency

about

Follow-up status during the first 5 years of life for metabolic disorders on the federal Recommended Uniform Screening Panel.

P2860

Q46152889-14190925-C8EC-40DB-A0FC-0B1FEE77A243

P2860

The Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD Deficiency

Item

http://www.wikidata.org/entity/Q36894924

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD Deficiency

@en

type

Item

label

The Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD Deficiency

@en

prefLabel

The Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD Deficiency

@en

P1476

The Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD Deficiency

@en

P2093

Eugene Diekman

http://www.w3.org/2001/XMLSchema#string

Evert Ben van Veen

http://www.w3.org/2001/XMLSchema#string

Frits Wijburg

http://www.w3.org/2001/XMLSchema#string

Gepke Visser

http://www.w3.org/2001/XMLSchema#string

Hans Waterham

http://www.w3.org/2001/XMLSchema#string

Leo Kluijtmans

http://www.w3.org/2001/XMLSchema#string

Monique de Sain-van der Velden

http://www.w3.org/2001/XMLSchema#string

Peter Schielen

http://www.w3.org/2001/XMLSchema#string

Sacha Ferdinandusse

http://www.w3.org/2001/XMLSchema#string

P2860

Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.

The impact of false-positive newborn screening results on families: a qualitative study.

Law, ethics, and the duty of care.

Postanalytical tools improve performance of newborn screening by tandem mass spectrometry.

Fatty acid oxidation disorders: outcome and long-term prognosis.

The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.

Patients-in-waiting: Living between sickness and health in the genomics era.

Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result.

Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.

P304

101-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/8904_2015_476

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282732429

http://www.w3.org/2001/XMLSchema#string

P698

26453363

http://www.w3.org/2001/XMLSchema#string

P932

4864775

http://www.w3.org/2001/XMLSchema#string

The Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD Deficiency

about

P2860

P2860

The Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD Deficiency

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932